Importer of Controlled Substances Registration, 15633 [2018-07444]
Download as PDF
<![CDATA[
15633
Federal Register / Vol. 83, No. 70 / Wednesday, April 11, 2018 / Notices
authority is contingent on Respondent
being a practitioner with a valid DEA
registration, see 21 U.S.C. 823(g)(2)(A);
21 CFR 1301.28(a), I will revoke his
DATA-Waiver authority as well.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b), I order that DEA
Certificate of Registration No.
BZ5641419 and DATA-Waiver
Identification Number XZ5641419,
issued to Witold Marek Zajewski, M.D.,
be, and they hereby are, revoked. I
further order that any pending
application of Witold Marek Zajewski to
renew or modify the above registration,
or any pending application of Witold
Marek Zajewski for any other
registration in the State of Illinois, be,
and it hereby is, denied. This Order is
effective immediately.4
Dated: April 4, 2018.
Robert W. Patterson,
Acting Administrator.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
[FR Doc. 2018–07454 Filed 4–10–18; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
The companies listed below applied
to be registered as importers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Company
FR docket
Sharp (Bethlehem), LLC .....................................................
Catalent Pharma Solutions, LLC ........................................
Janssen Pharmaceuticals, Inc ............................................
Mylan Pharmaceuticals, Inc ...............................................
Meridian Medical Technologies, Inc ...................................
Noramco, Inc ......................................................................
Johnson Matthey, Inc .........................................................
Mylan Technologies, Inc .....................................................
Mylan Pharmaceuticals, Inc ...............................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
83
83
83
83
83
83
83
83
83
FR
FR
FR
FR
FR
FR
FR
FR
FR
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: April 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
amozie on DSK30RV082PROD with NOTICES
Jkt 244001
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
schedule I and II controlled substances.
SUMMARY:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
The companies listed below applied
to be registered as bulk manufacturers of
various basic classes of controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
FR docket
4 For the same reasons which led the IDFPR to
revoke Respondent’s controlled substance license, I
January 4, 2018.
January 16, 2018.
January 16, 2018.
February 9, 2018.
February 9, 2018.
February 9, 2018.
February 9, 2018.
February 9, 2018.
February 23, 2018.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2018–07444 Filed 4–10–18; 8:45 am]
Nanosyn, Inc .......................................................................
Janssen Pharmaceutical, Inc .............................................
Cambrex High Point, Inc ....................................................
AMPAC Fine Chemicals LLC .............................................
Organix, Inc ........................................................................
Johnson Matthey Inc ..........................................................
Chemtos, LLC .....................................................................
Alcami Wisconsin Corporation ...........................................
17:17 Apr 10, 2018
Published
539 ..........................................................................
2215 ........................................................................
2214 ........................................................................
5809 ........................................................................
5810 ........................................................................
5810 ........................................................................
5811 ........................................................................
5811 ........................................................................
8107 ........................................................................
Company
VerDate Sep<11>2014
SUMMARY:
82
82
82
82
83
83
83
83
FR
FR
FR
FR
FR
FR
FR
FR
56993 ......................................................................
58027 ......................................................................
61795 ......................................................................
61795 ......................................................................
150 ..........................................................................
2215 ........................................................................
2671 ........................................................................
2675 ........................................................................
conclude that the public interest necessitates that
PO 00000
Frm 00084
Published
Fmt 4703
Sfmt 4703
December 1, 2017.
December 8, 2017.
December 29, 2017.
December 29, 2017.
January 2, 2018.
January 16, 2018.
January 18, 2018.
January 18, 2018.
this Order be effective immediately. 21 CFR
1316.67.
E:\FR\FM\11APN1.SGM
11APN1
]]>Agencies
[Federal Register Volume 83, Number 70 (Wednesday, April 11, 2018)]
[Notices]
[Page 15633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07444]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of
various basic classes of controlled substances. Information on
previously published notices is listed in the table below. No comments
or objections were submitted and no requests for hearing were submitted
for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Sharp (Bethlehem), LLC................ 83 FR 539..................... January 4, 2018.
Catalent Pharma Solutions, LLC........ 83 FR 2215.................... January 16, 2018.
Janssen Pharmaceuticals, Inc.......... 83 FR 2214.................... January 16, 2018.
Mylan Pharmaceuticals, Inc............ 83 FR 5809.................... February 9, 2018.
Meridian Medical Technologies, Inc.... 83 FR 5810.................... February 9, 2018.
Noramco, Inc.......................... 83 FR 5810.................... February 9, 2018.
Johnson Matthey, Inc.................. 83 FR 5811.................... February 9, 2018.
Mylan Technologies, Inc............... 83 FR 5811.................... February 9, 2018.
Mylan Pharmaceuticals, Inc............ 83 FR 8107.................... February 23, 2018.
----------------------------------------------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrants to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
Dated: April 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07444 Filed 4-10-18; 8:45 am]
BILLING CODE 4410-09-P
